$115.31
-4.08-3.42%
가까이에: Nov 20, 4:00 PM EST
$124.06
8.757.59%
시간외: 5:38 PM EST
Kymera Therapeutics (KYMR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $-1.32 | $-1.27 | -3.94 % |
| Q2 | Aug 5, 2026 | $-0.62 | $-0.72 | 13.9 % |
| Q1 | Apr 30, 2026 | $-0.71 | $-0.86 | 17.4 % |
| Q4 | Feb 26, 2026 | $-0.97 | $-0.78 | -24.4 % |
Quarterly Revenue (Billions)
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $0 | $3.57M | -100.0 % |
| Q2 | Aug 5, 2026 | $65.00M | $32.56M | 99.6 % |
| Q1 | Apr 30, 2026 | $34.37M | $8.79M | 291.1 % |
| Q4 | Feb 26, 2026 | $2.87M | $16.25M | -82.3 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.27 | $-0.72 | $-0.86 | $-0.78 |
| Actual | $-1.32 | $-0.62 | $-0.71 | $-0.97 |
| Surprise | -3.94% | +13.9% | +17.4% | -24.4% |
| Revenue | ||||
| Estimate | $3.6M | $32.6M | $8.8M | $16.2M |
| Actual | $0 | $65.0M | $34.4M | $2.9M |
| Surprise | -100.0% | +99.6% | +291.1% | -82.3% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.29 | $-1.35 | $-1.40 | $-1.43 |
| Revenue | ||||
| Consensus | $1.4M | $7.6M | — | — |
